Luke T Lavallée1, Simon Tanguay2, Michael A Jewett3, Lori Wood4, Anil Kapoor5, Ricardo A Rendon6, Ronald B Moore7, Louis Lacombe8, Jun Kawakami9, Stephen E Pautler10, Darrel E Drachenberg11, Peter C Black12, Jean-Baptiste Lattouf13, Christopher Morash14, Ilias Cagiannos14, Zhihui Liu15, Rodney H Breau1. 1. Division of Urology, University of Ottawa, Ottawa, ON; ; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, ON; 2. Division of Urology, McGill University, Montreal, QC; 3. Division of Urology, University of Toronto, Toronto, ON; 4. Department of Medicine and Urology, Dalhousie University, Halifax, NS; 5. Division of Urology, McMaster University, Hamilton, ON; 6. Department of Urology, Dalhousie University, Halifax, NS; 7. Division of Urology, University of Alberta, Edmonton, AB; 8. Division of Urology, Université Laval, Quebec City, QC; 9. Division of Urology, University of Calgary, Calgary, AB; 10. Division of Urology, Western University, London, ON; 11. Division of Urology, University of Manitoba, Winnipeg, MB; 12. Department of Urologic Sciences, University of British Columbia, Vancouver, BC; 13. Division of Urology, Centre hospitalier de l'université de Montreal, Montreal, QC; 14. Division of Urology, University of Ottawa, Ottawa, ON; 15. Cancer Care Ontario, Toronto, Ontario, Canada.
Abstract
INTRODUCTION: The proportion of patients with stage 1 renal tumours receiving partial nephrectomy is considered a quality of care indicator. The objective of this study was to characterize surgical practice patterns at Canadian academic institutions for the treatment of these tumours. METHODS: The Canadian Kidney Cancer Information System (CKCis) is a multicentre collaboration of 13 academic institutions in Canada. All patients with pathologic stage T1 renal tumours in CKCis were identified. Descriptive statistics were performed to characterize practice patterns over time. Associations between patient, tumour, and treatment factors with the use of partial nephrectomy were determined. RESULTS: From 1988 to April 2014, 1453 patients with pathologic stage 1 renal tumours were entered in the CKCis database. Of these, 977 (67%) patients had pT1a tumours; of these, 765 (78%) received partial nephrectomy. Of the total number of patients (1453), 476 (33%) had pT1b tumours; of these, 204 (43%) received partial nephrectomy. The use of partial nephrectomy increased over time from 60% to 90% for pT1a tumours and 20% to 60% for pT1b tumours. Stage pT1b (relative risk [RR] 0.56, 95% confidence interval [CI] 0.50-0.63) and minimally invasive surgical approach (RR 0.78, 95% CI 0.73-0.84 for pT1a and RR 0.23, 95% CI 0.17-0.30 for pT1b) were associated with decreased use of partial nephrectomy. Most patient factors including age, gender, body mass index, hypertension, and renal function were not significantly associated with use of partial nephrectomy (p > 0.05). CONCLUSION: Almost all pT1a and most pT1b renal tumours managed surgically at academic centres in Canada receive partial nephrectomy. The use of partial versus radical nephrectomy appears to occur independently of patient age and comorbid status, which may indicate that urologists are performing partial nephrectomy whenever technically feasible based on tumour factors. Although the ideal proportion patients receiving partial nephrectomy cannot be determined, treatment distribution observed in this cohort may indicate an achievable case distribution among experienced surgeons.
INTRODUCTION: The proportion of patients with stage 1 renal tumours receiving partial nephrectomy is considered a quality of care indicator. The objective of this study was to characterize surgical practice patterns at Canadian academic institutions for the treatment of these tumours. METHODS: The Canadian Kidney Cancer Information System (CKCis) is a multicentre collaboration of 13 academic institutions in Canada. All patients with pathologic stage T1 renal tumours in CKCis were identified. Descriptive statistics were performed to characterize practice patterns over time. Associations between patient, tumour, and treatment factors with the use of partial nephrectomy were determined. RESULTS: From 1988 to April 2014, 1453 patients with pathologic stage 1 renal tumours were entered in the CKCis database. Of these, 977 (67%) patients had pT1a tumours; of these, 765 (78%) received partial nephrectomy. Of the total number of patients (1453), 476 (33%) had pT1b tumours; of these, 204 (43%) received partial nephrectomy. The use of partial nephrectomy increased over time from 60% to 90% for pT1a tumours and 20% to 60% for pT1b tumours. Stage pT1b (relative risk [RR] 0.56, 95% confidence interval [CI] 0.50-0.63) and minimally invasive surgical approach (RR 0.78, 95% CI 0.73-0.84 for pT1a and RR 0.23, 95% CI 0.17-0.30 for pT1b) were associated with decreased use of partial nephrectomy. Most patient factors including age, gender, body mass index, hypertension, and renal function were not significantly associated with use of partial nephrectomy (p > 0.05). CONCLUSION: Almost all pT1a and most pT1b renal tumours managed surgically at academic centres in Canada receive partial nephrectomy. The use of partial versus radical nephrectomy appears to occur independently of patient age and comorbid status, which may indicate that urologists are performing partial nephrectomy whenever technically feasible based on tumour factors. Although the ideal proportion patients receiving partial nephrectomy cannot be determined, treatment distribution observed in this cohort may indicate an achievable case distribution among experienced surgeons.
Authors: Andreas Becker; Praful Ravi; Florian Roghmann; Quoc-Dien Trinh; Zhe Tian; Alexandre Larouche; Simon Kim; Shahrokh F Shariat; Luis Kluth; Roland Dahlem; Margit Fisch; Markus Graefen; Christian Eichelberg; Pierre I Karakiewicz; Maxine Sun Journal: Urology Date: 2014-06 Impact factor: 2.649
Authors: Hendrik Van Poppel; Luigi Da Pozzo; Walter Albrecht; Vsevolod Matveev; Aldo Bono; Andrzej Borkowski; Jean-Marie Marechal; Laurence Klotz; Eila Skinner; Thomas Keane; Ilse Claessens; Richard Sylvester Journal: Eur Urol Date: 2006-11-15 Impact factor: 20.096
Authors: John M Hollingsworth; David C Miller; Stephanie Daignault; Brent K Hollenbeck Journal: J Natl Cancer Inst Date: 2006-09-20 Impact factor: 13.506
Authors: Maxime Crépel; Claudio Jeldres; Maxine Sun; Giovanni Lughezzani; Hendrik Isbarn; Ahmed Alasker; Umberto Capitanio; Shahrokh F Shariat; Philippe Arjane; Hugues Widmer; Markus Graefen; Francesco Montorsi; Paul Perrotte; Pierre I Karakiewicz Journal: Urology Date: 2010-10 Impact factor: 2.649
Authors: David C Miller; John M Hollingsworth; Khaled S Hafez; Stephanie Daignault; Brent K Hollenbeck Journal: J Urol Date: 2006-03 Impact factor: 7.450
Authors: Alice Dragomir; Armen Aprikian; Anil Kapoor; Antonio Finelli; Frédéric Pouliot; Ricardo Rendon; Peter C Black; Ronald Moore; Rodney H Breau; Jun Kawakami; Darrell Drachenberg; Jean-Baptiste Lattouf; Simon Tanguay Journal: CMAJ Open Date: 2017-12-11